Cargando…
Multiple Routes to Oestrogen Antagonism
Several lines of evidence attest to the existence of alternative ligand binding sites on the oestrogen receptor (ER), including non-competitive inhibition by trilostane or tamoxifen. It is possible that the inhibitory action of conventional oestrogen agonists at high concentrations may indicate that...
Autores principales: | Glover, Hilary R., Barker, Stewart, Malouitre, Sylvanie D. M., Puddefoot, John R., Vinson, Gavin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034074/ http://dx.doi.org/10.3390/ph3113417 |
Ejemplares similares
-
Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast.
por: Barker, S., et al.
Publicado: (1989) -
Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples.
por: Baker, V. A., et al.
Publicado: (1992) -
Oestrogen and progesterone receptor distribution in the cancerous breast.
por: Panahy, C., et al.
Publicado: (1987) -
Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation
por: Malouitre, Sylvanie, et al.
Publicado: (2009) -
A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes
por: Dube, Henry, et al.
Publicado: (2012)